Financial Data and Key Metrics Changes - In Q4 2025, CI&T reported record revenue of $134.3 million, reflecting a 19.3% organic growth compared to Q4 2024, and a 13.9% growth on a constant currency basis [6][24] - For the full year 2025, total revenue reached $489.7 million, marking an 11.5% increase over 2024, or 13.2% on a constant currency basis [24] - Adjusted EBITDA margin for Q4 was 18.4%, with adjusted profit margin at 14% [7][27] - Full year adjusted EBITDA was BRL 89.4 million, up 9.1% from 2024, resulting in a full year margin of 18.3% [27][29] Business Line Data and Key Metrics Changes - CI&T's AI-powered offerings have expanded the pipeline and increased engagement quality, leading to a 10x productivity increase in some client cases [8][20] - The company has embedded AI into core offerings, entering an acceleration phase that enhances value delivery [8][24] Market Data and Key Metrics Changes - Latin America experienced a remarkable 26.8% revenue growth for the full year, driven by digital and AI modernization [25] - North America maintained a steady growth trajectory with a 9.2% year-over-year revenue increase [25] Company Strategy and Development Direction - CI&T is focused on transforming its operating model to scale AI across enterprises, emphasizing the importance of aligning people, processes, and technology [5][6] - The company is transitioning to modern engagement models, moving from time and materials to fixed price, outcome-based, and consumption-based contracts [18][80] - CI&T aims to redefine the unit economics of software production, capturing significant performance arbitrage through AI-augmented solutions [17][18] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in sustaining growth while investing in an AI-native operating model, projecting Q1 2026 revenue of at least $134.7 million, representing 21.5% year-over-year growth [31] - The company anticipates a favorable FX tailwind of approximately 300 basis points for 2026 [31] Other Important Information - CI&T was recognized as a leader in enterprise data modernization and AI services by ISG, and earned the AWS Generative AI Services Competency seal [22][21] - The company has a strong pipeline, with a 30% increase compared to the same period last year, driven by AI demand [36] Q&A Session Summary Question: Guidance and Assumptions for Q1 - Management indicated a strong exit rate for Q4 and a solid commercial pipeline, with macro uncertainty reflected in the lower end of guidance [35] Question: Impact of Geopolitical Uncertainty - No significant impacts from geopolitical uncertainty were observed in Q1 [37] Question: Performance of Top Clients - Revenue from top 10 clients grew 16.5% year-over-year, with strong expansion across all cohorts [42] Question: AI and Agentic Activity Mix - Demand is categorized into foundational spending for legacy modernization and direct AI investments for hyper-efficiency [49] Question: Adjusted EBITDA Margin Drivers - Investments in workforce and AI platforms contributed to margin fluctuations, with expectations for gradual recovery as productivity tools are rolled out [51] Question: Alternative Billing Models - CI&T is experimenting with various billing models, including outcome-based contracts, which could enhance margins over time [80]

Financial Data and Key Metrics Changes - The company finished fiscal 2025 with total net sales of $155.1 million, an increase of 5.3% despite having 17 fewer stores than the previous year [11] - Comparable net sales for the fourth quarter increased by 10.1%, with physical stores and e-commerce contributing increases of 10.3% and 9.8% respectively [11] - Gross margin improved to 33.2% of net sales, an increase of 720 basis points compared to 26% last year [12] - Net income improved to $2.9 million or $0.10 per diluted share, compared to a net loss of $13.7 million or $0.45 per share last year [16] Business Line Data and Key Metrics Changes - Total net sales from physical stores increased by 3.6% despite a 7.1% reduction in store count, representing 72.3% of total net sales [12] - E-commerce net sales represented 27.7% of total net sales, up from 26.5% last year [12] - Product margins improved by 470 basis points due to higher initial markups and lower markdowns associated with reduced inventory [13] Market Data and Key Metrics Changes - The company experienced 6 consecutive months of positive comparable sales momentum, with 18 consecutive positive comp weeks leading into fiscal 2026 [4] - February 2026 saw a +20% comparable net sales result, indicating strong early momentum for fiscal 2026 [4] Company Strategy and Development Direction - The company is shifting from a store closure strategy to a disciplined approach to new store openings, planning to open 4-6 new stores in fiscal 2026 [7] - Significant investments in infrastructure and technology, including an AI-driven merchandise allocation tool, are expected to enhance operational efficiencies [8] - The company aims to continue building on the progress made in fiscal 2025, focusing on optimizing operations and improving customer engagement through enhanced marketing strategies [6][9] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's turnaround, noting that fundamentals are fixed and top-line growth is expected to continue [9] - The company is not yet profitable on an annualized basis but sees a clear path to profitability after generating profit in two of the last three quarters [9] - Management highlighted the importance of consumer spending environment for future growth, indicating that macroeconomic conditions could impact discretionary retail spending [28] Other Important Information - The company ended fiscal 2025 with total liquidity of $87.8 million, including cash of $46.3 million and no debt [16] - Total capital expenditures for fiscal 2025 were $4.7 million, down from $8.2 million in fiscal 2024 [16] Q&A Session Summary Question: Composition of strong comp for the fourth quarter - Management noted significant acceleration in comp sales from +1% in August to +20.1% in February, with strong traffic and conversion rates across all departments [23] Question: What is driving higher traffic? - Management indicated strength across all categories, improved inventory health, and effective marketing strategies as key drivers of higher traffic [25][26] Question: Path forward on store expansion - Management expressed confidence in unit economics and plans to be more aggressive in store expansion in 2027, depending on consumer spending environment [28] Question: CapEx for store expansion - CapEx is expected to be in the range of $8-$9 million, with a focus on improving sales per square foot and regaining lost productivity [29][43] Question: Assumptions for profitability outlook - Management clarified that an 8%-9% comp increase does not correlate to a proportionate increase in SG&A, with ongoing efficiency improvements expected [48]

Financial Data and Key Metrics Changes - Total revenues for Q4 2025 were $38.9 million, up from $21.5 million in Q4 2024, primarily due to a technology transfer agreement with Merck [20] - For the full year 2025, revenue was $70.4 million compared to $59.3 million in 2024 [20] - Product gross margin for Q4 2025 was 64%, consistent with the full year 2025 gross margin, which also stood at 64%, an increase from 56% in the prior year [20][21] - Net income for Q4 2025 was $9.6 million, compared to a loss of $10.4 million in Q4 2024, while the net loss for the full year 2025 was $44 million, down from $65.3 million in 2024 [24][25] Business Line Data and Key Metrics Changes - The small molecule biocatalysis business returned to a healthy profit margin in 2025, with stabilization in revenue expected to fuel growth for the next 3-5 years [9] - The ECO Synthesis platform achieved significant milestones, including synthesizing 10 grams of commercially relevant siRNA and scaling up production to 100 grams, with plans to reach half a kilo by the end of 2026 [5][6] Market Data and Key Metrics Changes - The total addressable annual market for production technologies in RNA medicine is estimated to be $2 billion in five years, with a growing demand for siRNA medicines at a rate of 5%-10% per year [4][5] - The industry is projected to require 10-30 metric tons of oligonucleotide material by 2030, indicating a significant addressable market for the company [55] Company Strategy and Development Direction - The company aims to establish itself as a key technology provider in the RNA medicine market, focusing on the ECO Synthesis platform to address production challenges [4][5] - Plans for 2026 include scaling up the ECO Synthesis manufacturing platform, achieving half-kilogram scale, and beginning construction of a GMP facility to support customer needs [7][28] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the demand for siRNA therapeutics and the company's ability to meet this demand through innovative technology [55] - The company anticipates that 2026 will be a year of significant progress, with a revenue target of $72 million to $76 million, and expects to maintain stable gross margins [25][27] Other Important Information - The company ended 2025 with $78.2 million in cash equivalents, expected to fund operations and capital expenditures through the end of 2027 [25] - A restructuring charge of $3.4 million was recorded in Q4 2025 as part of efforts to reduce operating costs and improve gross margins [24] Q&A Session Summary Question: Potential value for stereoisomer control - Management is actively exploring the biological activity of stereo configurations generated by the ECO Synthesis platform and plans to present data at the TIDES USA meeting [31][32] Question: Understanding the recent announced deal - The recent deal involves a small organization with a cardiovascular asset, and discussions have been ongoing for many months to address their manufacturing challenges [35][39] Question: Details on the 50-gram contract - The initial agreement is for preclinical work, and if successful, the company will progress to IND submissions and potentially commercial agreements for larger quantities [41][43] Question: Revenue guidance visibility - Management indicated that a significant portion of the $72 million-$76 million revenue guidance is based on historical buying practices, with some speculative elements due to the early part of the year [49][50] Question: Industry demand for siRNA - Management noted that the siRNA therapeutic pipeline is vibrant, with a growing number of assets in clinical trials, projecting a significant increase in demand by 2030 [53][55] Question: Revenue mix and growth expectations - The company expects growth to primarily come from the ECO side of the business, while the small molecule biocatalysis business is expected to stabilize and contribute to growth over the next few years [60][63]

Financial Data and Key Metrics Changes - The company reported total net sales of $155.1 million for Q4 2025, an increase of 5.3% year-over-year despite having 17 fewer stores [12] - Comparable net sales for the 13-week period ended January 31, 2026, increased by 10.1%, with physical stores up 10.3% and e-commerce up 9.8% [12] - Gross margin improved to 33.2% of net sales, an increase of 720 basis points compared to 26% last year [13] - Net income improved to $2.9 million or $0.10 per diluted share, compared to a net loss of $13.7 million or $0.45 per share last year [16] Business Line Data and Key Metrics Changes - Total net sales from physical stores increased by 3.6% despite a 7.1% reduction in store count, representing 72.3% of total net sales [13] - E-commerce net sales represented 27.7% of total net sales, up from 26.5% last year [13] - Product margins improved by 470 basis points due to higher initial markups and lower markdowns [14] Market Data and Key Metrics Changes - The company experienced 6 consecutive months of accelerating positive comparable sales momentum, with 18 consecutive positive comp weeks [4] - February 2026 saw a comparable net sales increase of 20.1% compared to the same period in 2025 [17] Company Strategy and Development Direction - The company plans to open 4-6 new stores in fiscal 2026, shifting from a store closure strategy to a disciplined approach to new openings [8] - Significant investments in infrastructure and technology, including an AI-driven merchandise allocation tool, are expected to enhance operational efficiencies [9] - The company aims to continue building on the progress made in fiscal 2025 and is optimistic about its prospects for fiscal 2026 [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the turnaround, noting that the fundamentals are fixed and the top line is growing [10] - The company is not yet profitable on an annualized basis but sees a clear path to profitability after generating profit in two of the last three quarters [10] - Management highlighted the importance of consumer spending environment for future growth, indicating that macroeconomic conditions could impact discretionary retail spending [29] Other Important Information - Total capital expenditures for fiscal 2025 were $4.7 million, down from $8.2 million in fiscal 2024 [16] - The company ended fiscal 2025 with total liquidity of $87.8 million, including cash of $46.3 million and no debt [16] Q&A Session Summary Question: Composition of strong comp for the fourth quarter - Management noted significant acceleration in comp sales from month to month, with a strong conversion rate and improvements in traffic for both stores and e-commerce [22][23] Question: What is driving higher traffic? - Management indicated strength across all categories, with improvements in inventory levels and a stronger assortment contributing to better sales [26][27] Question: Path forward on store expansion - Management emphasized confidence in unit economics and the ability to execute, while remaining cautious about the consumer spending environment [29] Question: CapEx for store expansion - Management expects CapEx to be no greater than $8 million-$9 million, with a focus on improving sales per square foot [30][42] Question: Assumptions for profitability outlook - Management clarified that an 8%-9% comp increase does not correlate to a proportionate increase in SG&A, with ongoing efficiency improvements expected [44][47]

Financial Data and Key Metrics Changes - In Q4 2025, CI&T reported record revenue of $134.3 million, reflecting a 19.3% organic growth compared to Q4 2024, and a 13.9% growth on a constant currency basis [5][23] - For the full year 2025, total revenue reached $489.7 million, marking an 11.5% increase over 2024, or 13.2% on a constant currency basis [23][24] - Adjusted EBITDA margin for Q4 was 18.4%, with adjusted profit margin at 14% [6][26] - Full year adjusted EBITDA was BRL 89.4 million, up 9.1% from 2024, resulting in a full year margin of 18.3% [26][28] Business Line Data and Key Metrics Changes - CI&T's AI-powered offerings have expanded the pipeline and increased engagement quality, contributing to the overall growth [8] - The company has embedded AI into core offerings, entering an acceleration phase that enhances value delivery [7][8] Market Data and Key Metrics Changes - Latin America experienced a remarkable 26.8% revenue growth for the full year, driven by digital and AI modernization [24] - North America maintained a steady growth trajectory with a 9.2% year-over-year revenue increase [24] Company Strategy and Development Direction - CI&T's strategy focuses on AI transformation, emphasizing the need for organizations to redesign their culture and operating models to effectively scale AI [4][5] - The company is transitioning clients to modern engagement models, moving from time and materials to fixed price and outcome-based contracts, which allows for decoupling revenue from headcount [18][80] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in sustaining growth while investing in an AI-native operating model, projecting Q1 2026 revenue of at least $134.7 million, representing 21.5% year-over-year growth [31] - The company anticipates a favorable FX tailwind of approximately 300 basis points for 2026 [31] Other Important Information - CI&T was recognized as a leader in enterprise data modernization and AI services by ISG, and earned the AWS Generative AI Services Competency seal [21][22] - The company has a strong pipeline, with a 30% increase compared to the same period last year, driven by AI demand [36] Q&A Session Summary Question: Can you walk us through the guidance and assumptions for Q1? - Management indicated a strong exit rate for Q4 and a solid commercial pipeline, with guidance reflecting macro uncertainty at the lower end and strong demand at the higher end [35][36] Question: Are there any impacts from geopolitical uncertainty in Q1? - Management reported no significant impacts from geopolitical uncertainty, with strong starts in both Europe and the U.S. [37] Question: What is the expectation for performance from top clients in 2026? - Revenue from top 10 clients grew 16.5% year-over-year, with continued expansion expected, although at a slower pace for the top client [41][42] Question: Can you comment on the mix of new work and AI-led managed services? - Demand is categorized into foundational spending for legacy modernization and direct AI investments, with both areas seeing significant engagement [48][50] Question: What are the drivers of adjusted EBITDA margin going forward? - Management acknowledged investments in workforce and AI platforms as drivers of margin, with expectations for gradual recovery as productivity tools are rolled out [51][52] Question: How do you see the relationship between headcount growth and revenue growth? - Management anticipates a shift towards value-based pricing models, which will allow for increased revenue per employee over time [58][59] Question: What is the status of alternative billing models? - Management is experimenting with various models, including outcome-based pricing, which could enhance margins but will take time to fully implement [80][83]

Financial Data and Key Metrics Changes - For the full year 2025, Sonida's net operating income increased by more than 22% and adjusted EBITDA at share improved by 28% [8][18] - The company realized a 5.9% increase in revenue per occupied room (RevPOR) for Q4 compared to the same quarter in the prior year, with an annual growth of 8.8% [18][20] - The total portfolio NOI at share grew by 22% or $15 million on an annualized basis [20] Business Line Data and Key Metrics Changes - The same-store portfolio saw an additional 20 basis points of sequential occupancy gains in Q4, following a 90 basis points increase in Q3 [18] - The acquisition portfolio experienced a 680 basis point occupancy jump from 2024, with community NOI margin expanding by 550 basis points to 24.7% [19] - The 19 communities acquired in 2024 showed a sequential occupancy improvement of 290 basis points from Q3 to Q4, with total occupancy improving by 820 basis points year-over-year [9] Market Data and Key Metrics Changes - The company anticipates accelerated occupancy gains as the 19 communities from the 2024 acquisition cohort move into the same-store portfolio in 2026 [18] - The average annual rent renewal rate on in-place leases for the recent March 1 renewal was 7.9%, up from 6.8% the previous year [25] Company Strategy and Development Direction - The company completed the acquisition of CNL Healthcare Properties for a total consideration of $1.8 billion, enhancing competitive positioning and growth profile [5][6] - Sonida plans to prune approximately 10% of its portfolio based on community count to recycle capital into higher growth, newer vintage assets [22][39] - The focus will be on delivering excellent clinical care and services while developing a labor model that rewards strong employees [10][16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the merger's potential to drive improved performance trends and significant upside [10] - The company is committed to retaining and developing talent, with a focus on reducing employee turnover [16] - Management highlighted the importance of operational performance and advanced technology platforms to improve resident outcomes and efficiency [17] Other Important Information - The company has reached an agreement for the early conversion of Series A convertible preferred stock into common equity, simplifying its capital structure and reducing costs [14][15] - The commitment of a new upsized $405 million revolver will increase available capital for investment opportunities [13] Q&A Session Summary Question: Can you discuss the adjusted EBITDA and interest costs post-merger? - Management indicated that details will be provided in Q1, aiming for comparability with large-scale REIT reporters [36] Question: What is the timeline for pruning the 10% of the portfolio? - Management expects to make progress within 6 to 12 months, with proceeds first going to de-lever the company [39] Question: Is the 16%+ same-store NOI growth a good run rate number? - Management views it as a starting point and will provide more insights as they release normalized FFO metrics [40][41] Question: Is the 7.9% rate increase for the legacy pool or the current pool? - The rate increase is for the legacy pool that was pushed through recently [45] Question: Will net lease assets be part of the dispositions this year? - Management stated there are no immediate plans for net lease assets but will evaluate market opportunities [50]

Financial Data and Key Metrics Changes - For Q3 fiscal 2026, the company reported revenue of $16.9 million, which is down from $18.9 million in the same period of the prior fiscal year and essentially unchanged from the second fiscal quarter of this year [13][19] - The revenue from commercial and U.S. government satellite programs was approximately $4.2 million, accounting for 25% of total revenue, compared to $11.2 million or 59% in the same period of the prior fiscal year [13][14] - Consolidated net income for Q3 fiscal 2026 was approximately $1.6 million or $0.16 per share, compared to approximately $15.4 million or $1.60 per share for the same period of the previous fiscal year [20] Business Line Data and Key Metrics Changes - Revenue from non-space U.S. government and Department of Defense customers was $12.5 million, up from $7.4 million in the same period of the prior fiscal year, accounting for approximately 74% of consolidated revenue [14] - Other commercial and industrial revenues were approximately $180 thousand, down from approximately $367 thousand in the prior fiscal year [14] Market Data and Key Metrics Changes - The company’s backlog at the end of January 2026 was approximately $83 million, a new all-time high, compared to approximately $70 million for the previous fiscal year ended April 30, 2025 [21] - The company anticipates that backlog could exceed $100 million in the near future, supported by new contracts and ongoing business [6][21] Company Strategy and Development Direction - The company is focusing on growth in large and emerging markets, including quantum sensing and proliferated satellites, alongside its traditional space and defense businesses [3][4] - The management emphasized the importance of maintaining a balance between traditional and new business lines, expecting both to grow simultaneously [5] Management's Comments on Operating Environment and Future Outlook - The current geopolitical climate, including ongoing conflicts, is expected to drive demand for defense programs, which the company is heavily involved in [9][11] - Management expressed optimism about the future growth of the company, particularly in the defense sector and alternative positioning, navigation, and timing systems [12] Other Important Information - The company is debt-free and believes its liquidity is adequate to meet operating and investing needs for the next 12 months [22] - The company plans to continue investing in R&D to keep its products at the forefront of technology [18] Q&A Session Summary Question: Insights on proliferated satellite wins - Management noted that success in proliferated constellation deals is linked to providing a technical edge, while cost-driven contracts pose challenges [26][27] Question: Details on the $45 million contracts - Management indicated that both contracts are significant but did not disclose specific proportions [28][29] Question: Funded backlog timing - Management confirmed that the new contracts will significantly impact the current quarter's backlog [30] Question: Cost structure and operating expenses - Management clarified that some operating expenses are due to investments in Colorado, and they expect expenses to normalize [31][33] Question: Update on Turbo's market reception - Management expressed increased optimism about Turbo's revenue potential, expecting significant growth in the coming quarters [34][35] Question: Clarification on proliferated satellites - Management explained that proliferated satellites differ from traditional systems by having many more, less costly satellites, which allows for continuous production [40][42] Question: Gross margins on new satellite programs - Management anticipates lower gross margins initially for proliferated satellites but expects strong margins in the long run [48][49] Question: Alternative positioning and navigation systems - Management discussed ongoing projects in magnetic navigation and other non-satellite alternatives to GPS, with current revenue from development activities [88][95] Question: Impact of new contracts on backlog - Management confirmed that the new contracts could have a significant long-term impact on backlog, potentially following a 10x revenue realization pattern [99][100]

Financial Data and Key Metrics Changes - In Q4 2025, net sales decreased by 2.4% to $1.52 billion, with comparable sales down 1.6% [9][10] - For the full year 2025, Adjusted EBITDA increased by 21% to $408 million, with a margin of 6.8% [8][9] - Operating cash flow saw a significant increase of 77% year-over-year, contributing to a reduction in the leverage ratio from 4.2x to 3x [3][12] Business Line Data and Key Metrics Changes - The gross margin rate expanded by 66 basis points to 38.7% for the full year, while operating margin improved by 190 basis points [8][9] - In Q4, gross profit dollars were $581 million, with a gross margin rate of 38.3% [10][11] - The services segment, including vet hospitals and grooming, is expected to continue growing, with a focus on improving productivity in existing locations [24][25] Market Data and Key Metrics Changes - The company ended 2025 with 1,382 stores in the U.S., having closed a total of 41 stores over the past two years [10][12] - The fresh food category is identified as a significant growth opportunity, with plans to add over 1,000 freezers to expand offerings [19][20] Company Strategy and Development Direction - The company is entering a new phase called "Reach for the Sky," focusing on sustainable top-line growth through four pillars: compelling product offerings, services at scale, trusted store experiences, and an integrated omni-channel model [17][18] - The strategy includes increasing product newness, launching new national brands, and enhancing the customer experience through store events and improved technology [19][28] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in starting 2026 from a position of strength, despite navigating a challenging macroeconomic environment [12][14] - The outlook for Q1 2026 anticipates net sales to be down 1% to flat, with expectations for positive comparable sales growth for the full year [14][32] Other Important Information - Free cash flow improved by 276% year-over-year to $187 million, with a cash balance of $257 million at year-end [12][9] - The company plans to relaunch its loyalty program to enhance customer engagement and retention [30][31] Q&A Session Summary Question: What will lead Petco's growth from here? - Management indicated that growth will come from all four strategic pillars simultaneously, with a focus on product newness and customer engagement [35][36] Question: What are the drivers of the increase in gross margins? - Management highlighted the focus on pricing, promotional strategies, and product mix as key levers for maintaining healthy gross margins [43][44] Question: How is the brand assortment evolving? - The company aims to cater to a broader customer base, balancing specialty and mainstream offerings to meet diverse customer needs [52][54] Question: What percentage of customers engage in services? - Management noted that there is significant room for growth in services, particularly in vet hospitals and grooming, which are integral to the customer experience [60][62] Question: How will the company capture customers who do not currently buy dog food? - The strategy includes leveraging technology to enable cross-selling opportunities and increasing engagement with existing customers [65][66]

Financial Data and Key Metrics Changes - For Q4 2025, revenue increased by 17% year-over-year to $397.6 million, with organic growth at 12% [15] - Adjusted EBITDA grew 53% year-over-year to $39.5 million, with margins expanding to 9.9% [18] - Full-year adjusted EBITDA for 2025 was $115 million, exceeding guidance of $104 million-$106 million [20] - The company increased its cash balance to $66 million, up from $36 million in the previous quarter [18] Business Line Data and Key Metrics Changes - The company served over 205,000 residents, a 10% increase year-over-year [15] - Script volume grew by 14% year-over-year, with vaccine script volumes up 3% [15][16] - Gross profit rose 27% to $85.5 million, with gross margins expanding to 21.5% from 19.8% [15] Market Data and Key Metrics Changes - The company anticipates a revenue forecast of $1.4 billion-$1.42 billion for 2026, reflecting new pricing from the IRA [13][21] - The long-term care pharmacy environment is evolving with ongoing consolidation and increasing operational complexity [10] Company Strategy and Development Direction - The company plans to offset anticipated EBITDA impacts from the IRA in 2026 and is focused on maintaining service levels and cash flow [9][10] - The company is actively engaged in discussions for potential acquisitions and greenfield startups to expand its operational footprint [19][53] - The company aims to balance profit contributions between generics and branded drugs, with 92% of prescriptions being generic [30] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's growth momentum despite industry changes, with a focus on durable growth and margin expansion [12][13] - The demographic shift with the aging population is expected to create a tailwind for the company [10] - Management acknowledged the challenges posed by the IRA but believes the company's scale and operational discipline will provide stability [10] Other Important Information - The company performed over 100,000 clinical interventions benefiting approximately 74,000 residents, demonstrating its operational and clinical value [6] - The company administered over 120,000 vaccines during the third and fourth quarters, with improved profitability year-over-year [8] Q&A Session Summary Question: Can you help us understand what's durable, what's vaccine, what's non-recurring in the quarter? - Management indicated that the run rate for EBITDA is approximately $110 million, with variability in Q4 not projected to continue [26] Question: Did the vaccine program contribute more this year than last year? - Management confirmed that the vaccine program continued to be significant in Q4, with improved reimbursement and profitability [28] Question: What were you able to get done from a contracting standpoint to better balance the two profit streams? - Management noted progress in aligning gross margin dollars with the high volume of generic prescriptions [30] Question: Is the gap between potential margin and realized margin still what it was a couple of quarters ago? - Management indicated that the gap has increased to approximately 90 basis points, reflecting investments for future profitability [31] Question: Can you discuss the opportunity around share gain with struggling competitors? - Management acknowledged potential opportunities arising from competitors facing challenges, particularly in the context of bankruptcy [42] Question: Are you seeing efficiencies and improvements in labor inflation? - Management clarified that efficiencies are primarily due to scaling the existing platform rather than improvements in labor inflation [43]

Financial Data and Key Metrics Changes - Total revenue for Q4 2025 was $224 million, down from $262 million in Q4 2024, reflecting the impact of trust and safety initiatives and a deliberate reset of the member base [24][25] - Bumble app revenue decreased to $181 million from $212 million year-over-year, while adjusted EBITDA was $72 million, representing a margin of 32%, compared to $73 million and 28% in the prior year [25][26] - For the full year, total revenue was $966 million, down from $1.07 billion in 2024, with adjusted EBITDA at $314 million, maintaining a margin of 32% [25][26] Business Line Data and Key Metrics Changes - Selling and marketing expenses were reduced to $161 million, representing 17% of revenue, compared to $259 million or 24% of revenue in the previous year, indicating a more focused approach to member acquisition [26] - Product development expenses increased to $96 million, or 10% of revenue, from $84 million or 8% in 2024, reflecting increased investment in core product innovation and platform modernization [26] Market Data and Key Metrics Changes - The company reported stabilization in Bumble app registrations and active users despite a significant reduction in performance marketing, which was cut by over 80% year-over-year [6][7] - Engagement quality improved, with week one retention in the U.S. up materially and monthly retention trending higher [9] Company Strategy and Development Direction - The company aims to lead in creating a woman-centric dating product, focusing on trust, authenticity, and member outcomes, while balancing investment in sustainable long-term growth with healthy margins [5][6] - A new cloud-native technology stack is being developed to enhance product innovation and member experience, with a targeted launch in Q2 2026 [11][12] - The company is shifting towards a chapter-based profile structure to enhance user engagement and storytelling, moving beyond traditional swiping mechanics [74][75] Management's Comments on Operating Environment and Future Outlook - Management believes the most challenging portion of the quality reset is behind them, with expectations for improved financial performance as product innovations are rolled out [29][30] - The company anticipates a lag between product improvements and financial performance metrics, with sequential stabilization in business metrics expected to reflect in future revenue growth [29][30] Other Important Information - The company generated $250 million in operating cash flow for the full year, with $239 million converting into free cash flow [27] - The company ended 2025 with $176 million in cash and cash equivalents and is in discussions to refinance existing debt obligations [28] Q&A Session Summary Question: What is the path to accelerate registrations and active users? - Management emphasized the importance of quality and safety in the membership overhaul, noting that stabilization during this transformation is a positive sign for future growth [35][36] Question: What are the factors leading to EBITDA margin improvement? - Management highlighted continued operating discipline and efficiency, with expectations for sustained high adjusted EBITDA margins throughout the year [40][41] Question: How will progress on the product revamp be measured? - Management stated that member outcomes will be the key performance indicators, focusing on satisfaction and successful connections [48] Question: What is the strategy for tech re-platforming investments? - Management confirmed that 2025 was an investment year, with continued investment expected in 2026, while also benefiting from efficiencies in AI application [50][51] Question: How significant is the potential of direct billing? - Management noted that direct billing has already contributed to gross margin expansion, with rapid adoption of Apple Pay among users [56][57] Question: Will new product initiatives be rolled out globally? - Management confirmed that the new tech stack will be applied to the entire portfolio, with a focus on group interactions and community building [60]